Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Segmental Mastectomy. Found 21 abstracts

no pagination
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. Breast J. 2017 Mar;23(2):169-76.
Winn JS, Baker MG, Fanous IS, Slack-Davis JK, Atkins KA, Dillon PM. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival. Oncology. 2016 Jan;91(3):135-42.
Powers BD, Montes JA, Nguyen DC, Nick DA, Daly MP, Davey A, Willis AI. Demographic risk factors impacting timely radiation therapy completion after breast conserving surgery. Am J Surg. 2015 Nov;210(5):891-5.
Telli ML, Jensen KC, Vinayak S, Kurian AW, Lipson JA, Flaherty PJ, Timms K, Abkevich V, Schackmann EA, Wapnir IL, Carlson RW, Chang PJ, Sparano JA, Head B, Goldstein LJ, Haley B, Dakhil SR, Reid JE, Hartman AR, Manola J, Ford JM. Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105. J Clin Oncol. 2015 Apr 06;33(17):1895-901.   PMCID: 4451172
Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?. Breast Cancer Res Treat. 2014 Feb;143(3):571-7.   PMCID: 4161134
Bleicher RJ, Sigurdson ER. Breast cancer. Introduction. Curr Probl Cancer. 2012 Sep;36(5):232-3.   PMCID: Editorial
Freedman GM, Anderson PR, Li T, Nicolaou N. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer. 2009 Mar;115(5):946-51.   PMCID: PMC2993502
Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009 Jul;74(3):689-94.   PMCID: PMC2720600
Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol. 2008 Aug;15(8):2263-71.
Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magnetic Resonance Imaging Clinics of North America. 2007 Aug;14(3):363-78.
O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surgical Clinics of North America. 2007 Apr;87(2):333-51.
Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006 Mar;24(7):1031-6.
Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM, Hwang YT, Mandelblatt JS. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer. 2002 May 15;94(10):2534-41.
Freedman GM, Hanlon AL, Fowble BL, Anderson PR, Nicoloau N. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol. 2002 Oct;20(19):4015-21.
Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys. 2001 Nov;51(3):679-90.
Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer. 2001 May 15;91(10):1862-9.
Freedman GM, Fowble BL. Local recurrence after mastectomy or breast-conserving surgery and radiation. Oncology (Huntingt). 2000 Nov;14(11):1561-81; discussion 1581-2, 1582-4.
Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, Chen PY, Vicini FA. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000 Jan;46(1):35-43.
Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Cancer. 2000 Mar 15;88(6):1403-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Segmental Mastectomy

Female Segmental Mastectomy Breast Neoplasms surgery pathology Local Neoplasm Recurrence Aged Middle Aged Neoplasm Staging Adult therapy radiotherapy Human Retrospective Studies 80 and over Aged Axilla Lymph Node Excision epidemiology Age Factors therapeutic use Risk Factors Lobular Carcinoma methods Middle Age Adjuvant Radiotherapy Carcinoma in Situ Follow-Up Studies Combined Modality Therapy Treatment Outcome Prognosis Survival Rate United States drug therapy diagnosis Medicaid Breast Antineoplastic Agents secondary Antineoplastic Combined Chemotherapy Protocols Intraductal Carcinoma-Noninfiltrating Estrogen Receptors Disease-Free Survival Neoplasm Invasiveness SEER Program Ductal Carcinoma-Breast Adjuvant Chemotherapy Mastectomy Incidence Registries su [Surgery] administration & dosage Radiotherapy Dosage Sentinel Lymph Node Biopsy Medicare adverse effects Reoperation Infiltrating Duct Carcinoma Tamoxifen Prospective Studies histology Young Adult Iridium Radioisotopes Fibrosis Progesterone Receptors Lymphatic Irradiation Intensity-Modulated Radiotherapy genetics etiology Radiation Oncology Insurance Coverage Benzamides ErbB-2 Receptor Basement Membrane Algorithms Disparities US Gov't Support-PHS Randomized Controlled Trials Triple Negative Breast Neoplasms statistics & numerical data Breast cancer Adolescent US Gov't Support-Non-PHS Male Breast Neoplasms Residual Neoplasm Computer-Assisted Radiotherapy Planning anatomy & Health Insurance Genomic Instability Mammography 10540-29-1 (Tamoxifen) Abdominal Neoplasms Photons Evidence-Based Medicine Carboplatin Treatment Failure BRCA2 Protein Surgery Re-Irradiation radiation effects Conformal Radiotherapy Medically Uninsured Lymphatic Metastasis erbB-2 Receptor utilization Hormone-Dependent Neoplasms Second Primary Neoplasms Deoxycytidine tu [Therapeutic Use] insurance Risk Assessment Outcome Assessment (Health Care) prevention & control Organ Size Pilot Projects rt [Radiotherapy] Time Factors Drug Administration Schedule Seer pa [Pathology] Brachytherapy Skin analogs & derivatives analysis Hormonal Antineoplastic Agents Male Breast conserving treatment Neoadjuvant Therapy Healthcare Disparities African Continental Ancestry Group Cohort Studies Risk BRCA1 Protein Actuarial Analysis Radical Mastectomy Radiation Dose-Response Relationship diagnostic imaging X-Ray Computed Tomography metabolism Mutation Organs at Risk Radiation Injuries Decision Trees Clinical Competence Gene Expression Profiling Disease Progression radiation therapy Hormonal) 0 (Antineoplastic Agents Multivariate Analysis Acute Disease radiography
Last updated on Monday, July 06, 2020